TREA

85667465 - ARIAD PHARMACEUTICALS

Follow

Information

  • Trademark
  • 85667465
  • Serial Number
    85667465
  • Filing Date
    July 02, 2012
    12 years ago
  • Transaction Date
    August 15, 2015
    9 years ago
  • Status Date
    August 14, 2015
    9 years ago
  • Published for Opposition Date
    June 11, 2013
    11 years ago
  • Location Date
    February 24, 2014
    10 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    PARKER, JUSTINE D
  • Attorney Docket Number
    02603-0003
    Attorney Name
    John P. Rynkiewicz
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ARIAD PHARMACEUTICALS
Case File Statements
  • D10000: "PHARMACEUTICALS"
  • GS0011: Diagnostic reagents, preparations and substances for medical laboratory use for detecting cancer; Diagnostic preparations for detecting genetic aberrations for scientific use; reagents, preparations and substances for the preparation or manufacture of pharmaceutical preparations for use in oncology, cardiovascular diseases including stroke, ocular disorders, central nervous system diseases and disorders including Alzheimer's and Parkinson's diseases, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, organ transplant rejection and metabolic disorders; diagnostic kits for detecting genetic predispositions comprising diagnostic reagents, preparations and substances for scientific or medical laboratory purposes; chemical and diagnostic reagents, preparations and substances for scientific purposes
  • GS0051: Diagnostic reagents, preparations and substances for medical use for detecting cancer; Diagnostic preparations detecting genetic aberrations for medical use; Pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases including stroke, ocular disorders, central nervous system diseases and disorders including Alzheimer's and Parkinson's diseases, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, organ transplant rejection and metabolic disorders; pharmaceutical preparations used in the treatment and/or prophylaxis of viral, pulmonary, genetic, renal, musculoskeletal, neurologic and gastrointestinal diseases; diagnostic kits for detecting genetic predispositions comprising diagnostic reagents, preparations and substances for medical purposes; diagnostic reagents, preparations and substances for medical purposes; Chemical preparations for medical purposes, namely, for use in oncology, for the treatment and prevention of cancer, cardiovascular diseases including stroke, ocular disorders, central nervous system diseases and disorders, Alzheimer's and Parkinson's diseases, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, organ transplant rejection and metabolic disorders, viral, pulmonary, genetic, renal, musculoskeletal, neurologic and gastrointestinal diseases
  • GS0091: Computer software for use in electronic storage and retrieval of medical data and medical information for healthcare professionals; computer software for personalized medicine purposes, namely scientific analysis of gene sequences; laboratory devices for detecting gene sequences
  • GS0101: Medical devices, namely, stents; Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the field of cancer; medical diagnostic apparatus for detecting cancer or a predisposition to cancer; coatings sold as an integral component of medical stents and other implantable medical devices; stents
  • GS0391: Electronic storage of medical data and medical information for healthcare professionals
  • GS0411: Educational classes, seminars, presentations and programs pertaining to cancer, pharmaceuticals, genetics
  • GS0421: Providing laboratory research services in the field of gene expression, namely, cancer biology; DNA analysis services; medical and scientific research in the field of pharmaceuticals, cancer treatment and diagnosis; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical research and scientific information in the field of cancer prevention, pharmaceuticals, screening, diagnosis and treatment
  • GS0441: Genetic testing and screening for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Medical services in the field of personalized medicine; cancer screening, diagnosis and treatment; providing medical information in the field of cancer prevention, screening, diagnosis and treatment; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of cancer
Case File Event Statements
  • 8/15/2015 - 9 years ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/14/2015 - 9 years ago
    33 - EXTENSION 4 GRANTED Type: EX4G
  • 8/6/2015 - 9 years ago
    32 - EXTENSION 4 FILED Type: EXT4
  • 8/6/2015 - 9 years ago
    31 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/20/2015 - 9 years ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/19/2015 - 9 years ago
    29 - EXTENSION 3 GRANTED Type: EX3G
  • 2/6/2015 - 10 years ago
    28 - EXTENSION 3 FILED Type: EXT3
  • 2/6/2015 - 10 years ago
    27 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/12/2014 - 10 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/11/2014 - 10 years ago
    25 - EXTENSION 2 GRANTED Type: EX2G
  • 8/5/2014 - 10 years ago
    24 - EXTENSION 2 FILED Type: EXT2
  • 8/5/2014 - 10 years ago
    23 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/27/2014 - 10 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/26/2014 - 10 years ago
    21 - EXTENSION 1 GRANTED Type: EX1G
  • 1/31/2014 - 11 years ago
    20 - EXTENSION 1 FILED Type: EXT1
  • 2/24/2014 - 10 years ago
    19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/31/2014 - 11 years ago
    18 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/14/2014 - 11 years ago
    17 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/6/2013 - 11 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/11/2013 - 11 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/11/2013 - 11 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/22/2013 - 11 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/6/2013 - 11 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/3/2013 - 11 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 4/24/2013 - 11 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/23/2013 - 11 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/23/2013 - 11 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/23/2013 - 11 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/23/2012 - 12 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/23/2012 - 12 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/23/2012 - 12 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/22/2012 - 12 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/11/2012 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/5/2012 - 12 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP